ExecutiveOrdersEO
MemoMemorandumClinton · D

Presidential Memorandum

Strengthening Drug Control Cooperation with Mexico

This 1996 presidential memorandum directs 13 specific measures to strengthen U.S.-Mexico cooperation against drug trafficking, including developing a binational drug control strategy, reviewing Southwest border counter-drug programs, controlling precursor chemicals, combating money laundering, improving law enforcement coordination, and employing high technology for eradication. It establishes reporting deadlines to the U.S.-Mexico High Level Contact Group and the President's Council on Counter-Narcotics.

Federal Register Open PDF 61 FR 16039

Impact dates

  1. ONDCP review of cooperative U.S.-Mexico efforts submitted to President's Council on Counter-Narcotics

  2. High Level Contact Group meeting in Mexico (December)

  3. Southwest border counter-drug review submitted to President's Council on Counter-Narcotics

  4. High technology study recommendations submitted to High Level Contact Group

  5. High Level Contact Group next meeting in United States (end of June)

  6. White paper on drug trafficking threat presented to High Level Contact Group

  7. Money laundering progress report to High Level Contact Group

  8. Law enforcement cooperation recommendations to High Level Contact Group

  9. Fugitive return progress report to High Level Contact Group

  10. Criminal prosecution information sharing progress report to High Level Contact Group

  11. Interim report on territorial sovereignty measures to High Level Contact Group

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Sectors

ChemicalsPharmaBanking & financeTechnology & software

Mechanisms

LicensingProcurement

Role pressure

  • AdverseDomestic producer — Essential and precursor chemical manufacturers face tighter controls and reporting requirements for drug manufacturing inputs
  • AdverseImporter — Cross-border chemical trade subject to enhanced scrutiny and potential diversion controls
  • UncertainDownstream manufacturer — Legitimate pharmaceutical manufacturers may face additional regulatory burden for products like rohypnol mentioned in diversion context
  • ProtectiveEquipment supplier — High technology and environmental protection equipment suppliers for eradication programs may benefit from coordinated bilateral procurement

Geographies

USMX

Exposure dates

  • — High Level Contact Group meeting in Mexico (December)

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

MMM3MALBAlbemarleGOOGLAlphabetAAPLAppleBACBank of AmericaBASFYBASFBLKBlackRockCTVACortevaDOWDowDDDuPontLLYEli LillyGSGoldman SachsHSBCHSBCQQQInvesco QQQ TrustJNJJohnson & JohnsonJPMJPMorgan ChaseLYBLyondellBasellMRKMerckMETAMeta PlatformsMSFTMicrosoftNVSNovartisNVDANVIDIAORCLOraclePFEPfizer

Confidence: medium · Policy alerts

Key directives

  • ONDCP to coordinate white paper on drug trafficking threat for June 1996 High Level Contact Group meeting
  • Director of ONDCP to develop binational drug control strategy with Mexico
  • ONDCP to organize multi-agency demand reduction expertise exchange with Mexico
  • Departments of Treasury, Justice, Defense, and other agencies to conduct comprehensive Southwest border counter-drug review, coordinated by ONDCP
  • DOJ to lead U.S.-Mexico Plenary Group to produce binational methamphetamine strategy
  • DOJ to lead Plenary Group to produce chemical controls strategy and action plan
  • State, Justice, Treasury to develop money laundering legislative recommendations and training plans through Plenary Group
  • DOJ to continue leading Plenary Group for bilateral law enforcement cooperation
  • DOJ to improve fugitive return mechanisms through Plenary Group
  • Plenary Group to produce recommendations on law enforcement and prosecutorial evidence access
  • ONDCP to coordinate interagency effort on territorial sovereignty measures with Justice, State, Treasury, Defense
  • ONDCP to coordinate interdepartmental high technology study with Defense, State, and other agencies

Who is ordered

Timeline

Immediate

  • Establishment of U.S.-Mexico High Level Contact Group on Drug Control (already met March 27, 1996)
  • Direction to ONDCP to coordinate white paper on drug trafficking threat

Near term (90d)

  • White paper presented to High Level Contact Group at June 1996 meeting
  • Progress reports on money laundering, law enforcement cooperation, fugitives, and criminal prosecution presented at June 1996 meeting
  • Interim report on territorial sovereignty measures at June 1996 meeting

Long term

  • Comprehensive Southwest border review submitted to President's Council on Counter-Narcotics within 180 days (by approximately October 5, 1996)
  • High technology study recommendations submitted to High Level Contact Group within 180 days
  • ONDCP review of cooperative efforts submitted to President's Council on Counter-Narcotics by December 31, 1996

Risks & tensions

  • Sovereignty concerns explicitly acknowledged throughout, requiring careful balancing of cross-border operations
  • Vague 'regular reports' and 'expeditiously' language creates implementation uncertainty for some directives
  • Reliance on Mexican government cooperation amid certification process creates political dependency
  • Methamphetamine and chemical control provisions touch on legitimate industrial chemical trade, creating regulatory tension
Presidential Memorandum: Strengthening Drug Control Cooperation with Mexico · Executive Orders